The 5-year OS rates were 46% in the HIPEC group versus 38% in the no-HIPEC group, they noted in Lancet Oncology. The trial ...

Oncoinvent announces positive interim results from phase 1/2a studies of Radspherin for treatment of peritoneal carcinomatosis: Oslo, Norway Tuesday, November 12, 2024, 18:00 Hrs ...

The multifocality and irregularity of peritoneal carcinomatosis complicates the within-lesion reproducibility of ADC measurements and the feasibility of accurate serial comparisons. Robust ...

There are plans to evaluate TPMs in patients with peritoneal metastases or carcinomatosis, including pancreatic and other gastrointestinal and ovarian cancers.

Dr. Lambert specializes in the care of patients requiring surgical treatment related to peritoneal carcinomatosis (cancer which has spread throughout the lining of the abdominal cavity) and ...

Researchers at University of California San Diego School of Medicine found an FDA-approved drug used to treat breast cancer ...

or primary peritoneal cancer. IMNN-001 is a DNA immunotherapeutic drug that consists of an interleukin (IL)-12 plasmid that allows for targeted expression of IL-12 to avoid toxicities and poor ...

Generalised eruptive keratoacanthoma of Grzybowski (GEKA) is a rare disease characterised by the sudden appearance of ...

and the Peritoneal Metastasis Research Fund. Confocal imaging and histology core studies were performed with support from the UCSD Specialized Cancer Support Center P30 grant 2P30CA023100. The ...

I can’t reduce all my cancer risk through surgery. For example, BRCA1 carriers have a higher risk of pancreatic and peritoneal cancer, neither of which have a reliable screening tool.

You’re more likely to get this if your cancer is advanced. Peritoneal cancer is related to the most common kind of ovarian cancer. The two illnesses cause some of the same symptoms. Find out ...